The University of Maryland School of Medicine will lead a research study on an experimental vaccine to prevent swine flu.
The school’s Center for Vaccine Development will participate in a nationwide network of vaccine evaluation teams funded by the National Institutes of Health.
Starting in August, the clinical trial will enroll as many as 1,000 adults and children at 10 centers to evaluate the safety of the vaccine and measure its ability to stimulate immune responses to the H1N1 influenza virus.